Teva to Pay $420M to Settle Shareholders' Generic Drug Pricing Lawsuit — Report - TipRanks.com
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion | Reuters.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3ZLQVG3RKRKZXP5GGVOJ2PKLGQ.jpg "TEVA.TA - | Stock Price & Latest News | Reuters")
TEVA.TA - | Stock Price & Latest News | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/EDAT5T7QVVOGZP6VRKJB4IAP5E.jpg "Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters")
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTTVJLJBQNLRBHDEX576PT7LII.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
U.S. states sue Mylan, Teva, others for fixing drug prices - Mitchell Republic | News, weather, sports from Mitchell South Dakota
Averting opioid trial, Teva, drug distributors reach last-gasp settlement - The Jerusalem Post
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
A Teva Pharmaceutical Industries building is seen in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy
Netanyahu Asks Teva Pharm to Minimize Job Loss in Israel
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Opioid Maker Teva Proposes $4.35 Billion in Nationwide Settlement - Business - Haaretz.com
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UPSKKGKZ55OQZNWMYXEUSFQYVA.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva, Texas strike opioid settlement worth $225M | Business Insurance
Teva lied about opioid role, New York says | Reuters
Teva reaches proposed settlement of opioid lawsuits | Business Insurance
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UPSKKGKZ55OQZNWMYXEUSFQYVA.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva may pay as much as $3.6 billion in opioid settlement | Business Insurance
